Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Bupivacaine Liposome Adductor Canal Block on Muscle Strength After Total Knee Arthroplasty.

NCT07616102 is registered in ClinicalTrials.gov with General Hospital of Ningxia Medical University as lead sponsor.

NCT NCT07616102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07616102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Bupivacaine Liposome Adductor Canal Block on Muscle Strength After Total Knee Arthroplasty.
Lead sponsor
General Hospital of Ningxia Medical University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 10, 2026
Completion date
November 3, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

muscle strength, tka